Dow Up 0.19% Nasdaq Up 0.56%

Lpath Inc. (LPTN)

-NasdaqCM
2.60 Down 0.04(1.51%) 4:00PM EST
Prev Close:2.64
Open:2.59
Bid:2.59 x 600
Ask:2.60 x 500
1y Target Est:14.00
Beta:-0.44
Next Earnings Date:N/A
Day's Range:2.55 - 2.60
52wk Range:2.55 - 5.30
Volume:12,161
Avg Vol (3m):30,275
Market Cap:50.12M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):65.00
P/S (ttm):7.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Dec-14) :-0.34
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback